Growth Stocks

Although growth stock picks can be highly volatile, they can make good long-term investments. They may be well-known stars or quiet gems, but they do share one common attribute—they are growing at a higher-than-average rate within their industry, or within the market as a whole, and could keep growing for years or decades.

And keep in mind that we focus on growth stocks, which have a good long-term history and favourable prospects. We downplay momentum stocks that tend to attract many investors simply because they are moving faster than the market averages, but are liable to fall sharply when their momentum fades.

There’s room for growth stock investing in your portfolio, but make sure you follow our TSI Network three-part Successful Investor strategy for your overall portfolio:

  1. Invest mainly in well-established companies;
  2. Spread your money out across most if not all of the five main economic sectors (Manufacturing & Industry; Resources & Commodities; Consumer; Finance; Utilities);
  3. Downplay or avoid stocks in the broker/media limelight.

Make better stock picks when you read this FREE Special Report, Canadian Growth Stocks: WestJet Stock, RioCan Stock and More.

Read More Close
Growth Stocks Library Archives
TWILIO INC., $68.76, is a buy. The company (Nasdaq symbol TWLO; TSINetwork Rating: Extra Risk) (www.twilio.com; Shares outstanding: 173.3 million; Market cap: $13.0 billion; No dividends paid) now plans to lay off 11% of its workforce....
The plunge for many tech/platform stocks since the start of this year has hit both high-growth stocks with strong prospects as well as others with weaker outlooks that you should remain wary of despite broker/media praise for their business models. Here’s an example of a stock to stay away from:


WAG! GROUP CO., $3.33, (Nasdaq symbol PET; TSINetwork Rating: Speculative) (www.wag.co; Shares o/s: 37.9 million; Market cap: $126.3 million; No dividend) is the developer of a mobile-first technology platform that provides on-demand and scheduled pet-care services such as dog walking, training, pet sitting, etc....

WALT DISNEY CO., $98.99, is a buy. The company (New York symbol DIS; TSINetwork Rating: Above Average) (www.disney.com; Shares o/s: 1.8 billion; Market cap: $179.5 billion; No dividend) has now added Carolyn Everson, a veteran technology and media executive, most recently president of grocery delivery company Instacart, to its board of directors....
One Successful Investor way to cut IPO risk is to wait till a new issue has survived a market slump. 2019 IPO PagerDuty dropped to near $13 in March 2020 as COVID-19 took hold. But its business has continued to prosper by applying artificial intelligence (AI) to help customers shorten or avoid disruptions and to save money. We recommend this stock as a Power Buy.


PAGERDUTY INC., $22.47, is a buy. The company (New York symbol PD; TSINetwork Rating: Extra Risk) (www.pagerduty.com; Shares outstanding: 89.2 million; Market cap: $2.1 billion; No dividends paid) operates a platform that collects real-time data from software systems and devices and then notifies its IT customers of any incident that could harm their operations.


PagerDuty’s platform sits on top of a company’s technology systems, taking in data....
Eli Lilly discovers, develops, manufactures, and markets human pharmaceutical products—and it now has an obesity drug with a bright future that’s being fast-tracked by the FDA.


ELI LILLY & CO., $329.29, is a buy. The company (New York symbol LLY; TSINetwork Rating: Above Average) (www.lilly.com; Shares o/s: 950.2 million; Market cap: $318.3 billion; Dividend yield: 1.2%) said that the U.S....
MERCK & CO. INC., $93.26, is a #1 Power Buy for 2022. The drugmaker (New York symbol MRK; TSINetwork Rating: Above Average) (www.merck.com; Shares outstanding: 2.5 billion; Market cap: $239.7 billion; Dividend yield: 3.0%) has now exercised an option to jointly develop and potentially sell an mRNA-based cancer vaccine along with Moderna (symbol MRNA on Nasdaq).


The vaccine, mRNA-4157, is being tested in conjunction with Merck’s blockbuster cancer immunotherapy Keytruda, in a mid-stage trial for patients with high-risk melanoma....
We continue to see attractive investment opportunities for our subscribers in top drug stocks—and that includes AbbVie Inc. At the same time, over the years, we’ve found that spinoffs are about as close as you can get to a sure thing in investing. It’s one key reason why we think AbbVie—itself a spinoff—has further gains ahead for investors. We recommend this stock as a Power Buy.


ABBVIE INC., $143.13, is a buy. The company (New York symbol ABBV; TSINetwork Rating: Above Average) (www.abbvie.com; Shares outstanding: 1.8 billion; Market cap: $255.7 billion; Dividend yield: 3.9%) was formed on January 3, 2013, when Abbott Laboratories (symbol ABT on New York) split into two publicly traded companies.


Since its spinoff from Abbott Laboratories, AbbVie has depended heavily on its Humira drug to drive both its sales and earnings....
Shares of commercial real estate specialist Colliers fell to $49 in March 2020 due to the onset of COVID-19. Now that the pandemic is easing, the stock has more than doubled. We feel Colliers can move even higher on rising demand for its services as offices re-open, or are converted to other uses such as residential units.


COLLIERS INTERNATIONAL GROUP INC....
RIOCAN REAL ESTATE INVESTMENT TRUST $18 is a buy. The REIT (Toronto symbol REI.UN; Aggressive Growth Portfolio, Manufacturing & Industry sector; Units outstanding: 309.1 million; Market cap: $5.6 billion; Price-to-sales ratio: 4.7; Distribution yield: 5.7%; TSINetwork Rating: Average; www.riocan.com) owns all or part of 202 shopping centres and other properties, including 12 currently under development....
More regions are now re-opening their economies as the COVID-19 pandemic eases. That’s good news for fast-food operator Restaurant Brands, which aims to spur its long-term growth by expanding its overseas operations, which currently supply just 10% of its revenue.
RESTAURANT BRANDS INTERNATIONAL INC....